Key statistics
As of last trade Karyopharm Therapeutics Inc (25K:BRN) traded at 0.645, 0.00% below its 52-week high of 0.645, set on Sep 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.644 |
---|---|
High | 0.645 |
Low | 0.644 |
Bid | 0.627 |
Offer | 0.634 |
Previous close | 0.645 |
Average volume | 2.00k |
---|---|
Shares outstanding | 124.68m |
Free float | 112.71m |
P/E (TTM) | -- |
Market cap | 92.15m USD |
EPS (TTM) | -0.8356 USD |
Data delayed at least 15 minutes, as of Sep 13 2024.
More ▼
Press releases
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm to Participate at Upcoming Investor Conferences
- Karyopharm Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
- Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024